Result
€221,958 ▲ 172%
The result rose in 2025 from €81,520 to €221,958.
NEJAC
Lifetime
3 annual accounts with figures on one time axispeak €305,577 (2025)
€305,577▲ 158%
lowest -€4,365 (2023)
€221,958▲ 172%
peak €303,114 (2025)
€303,114▲ 273%
€100,034▲ 87.4%
Board1 name since 2023
1 director
Documentsfilings and deeds
24-06-202637 days before the deadline
2025micro format
Gross margin from €118,414 to €305,577Result from €81,520 to €221,958Registered office moved within Denderleeuw 14-07Equity from €81,155 to €303,114Debts from €53,382 to €100,034Cash from €11,098 to €56,026
Key points
from the 2025 annual accountsLiquidity
3.95 was 2.11 in 2024
Short-term debts rose from €47,801 to €97,618.
Position in the sector
€221,958
Higher net result than 90% of companies in human health. Sector median €59,542 · 21,298 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 39,274 companies had the same profile as NEJAC has now. Each dot stands for 99 companies, two years later.
95.8%
were still trading
2.3%
stopped another way
1.8%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 39,274 companies, not a prediction for NEJAC. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1003129755
Registered office moved within Denderleeuw
New registered office: De Nayerstraat, 32-9470 Denderleeuw · Previous registered office: Paardekastanje, 30-9470 Denderleeuw · General meeting of 13-05-2025 · Gazette deed
First establishment
De Nayerstraat 32, Denderleeuw
Incorporation
Founder: · 1,000 shares · Appointment: (director) · published on 11-12-2023 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| NEJAC Denderleeuw | €403,148 | €305,577 | 75.2% | - |
| E.J. MEDICAL Ninove | €406,163 | €334,664 | 46.9% | - |
| Dr. Jeroen Dauw Laarne | €465,859 | €312,269 | 83.3% | - |
| FOGIE Seraing | €415,932 | €295,987 | 63.3% | - |
| Bothy MDx Fernelmont | €377,536 | €284,491 | 88.8% | - |
| AMERA Ypres | €393,869 | €335,038 | 77.1% | - |
| ORTHOLIB Namur | €380,203 | €283,577 | 97.7% | - |
These companies have the same main activity as NEJAC: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €378,000 and €466,000, founded between 2023 and 2024.
Official details
Source: KBO- Status
- Active since 07-12-2023Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.360.556.9609470 Denderleeuw, since 05-03-2024
- Financial year end
- 31 December
- Peppol
- Reachable since 18-01-2026
Annual accounts 2025
- ≈ €460,000estimated
- €403,148▲ 200%
- Filing
- Filed on 24-06-2026, 37 days before the end of the filing period
Insights on NEJAC
NEJAC files the micro format. That format states no turnover. The gross margin rose from -€4,315 in 2023 to €305,577 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about NEJAC
- What is the company number of NEJAC?
- The company number of NEJAC is 1003.129.755. The VAT number is the same number with BE in front: BE 1003.129.755.
- Where is NEJAC based?
- The registered office is at De Nayerstraat 32, 9470 Denderleeuw.Company details
- What does NEJAC do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of NEJAC?
- NEJAC is a private limited company (BV).
- When was NEJAC founded?
- NEJAC was founded on 07-12-2023.
- Is NEJAC still active?
- Yes, NEJAC is an active enterprise in the KBO register.
- What is the turnover of NEJAC?
- The turnover in financial year 2025 is ≈ €460,000. This figure is estimated from the gross margin of €305,577 and 30 comparable companies (NACE 86220). It probably lies between €420,000 and €640,000.Financials
- Is NEJAC profitable?
- In financial year 2025, NEJAC made a profit of €221,958.
- Where can I find the annual accounts of NEJAC?
- NEJAC filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of NEJAC due?
- NEJAC must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.